Billets de Michelle Dawson

Billet publié sur Twitter/X le 30/11/2012 10:20

Twitter/X Publication avec DOI crossref Question posée par Dawson dans le billet Lien intégré au billet Termes sur l’autisme

Liens cités structurés

1 ressource citée

Publication avec DOI Récupéré Publication crossref

Jacob A.S. Vorstman, Richard J.L. Anney, Eske M. Derks, Louise Gallagher, Michael Gill, Maretha V. de Jonge, Herman van Engeland, René S. Kahn, et al. (2013). No evidence that common genetic risk variation is shared between schizophrenia and autism. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 162(1), 55-60. Wiley.

Date de publication
28/11/2012
Identifiant
10.1002/ajmg.b.32121
Auteurs
Jacob A.S. Vorstman, Richard J.L. Anney, Eske M. Derks, Louise Gallagher, Michael Gill, Maretha V. de Jonge, Herman van Engeland, René S. Kahn, Roel A. Ophoff, the Autism Genome Project, the International Schizophrenia Consortium
Source
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
Détails
162(1), 55-60
Type de référence
article
Éditeur
Wiley
Source de métadonnées
crossref

Résumé

Abstract The similarity between aspects of the clinical presentation of schizophrenia and autism spectrum disorders (ASD) suggests that elements of the biological etiology may also be shared between these two disorders. Recently, an increasing number of rare, mostly structural genetic variants are reported to increase the risk of both schizophrenia and ASD. We hypothesized that given this evidence for a shared genetic background based on rare genetic variants, common risk alleles may also be shared between ASD and schizophrenia. To test this hypothesis, the polygenic score, which summarizes the collective effect of a large number of common risk alleles, was used. We examined whether the polygenic score derived from a schizophrenia case–control dataset, previously reported by Purcell et al., was able to differentiate ASD cases from controls. The results demonstrate that the schizophrenia‐derived polygenic score is not different between ASD cases and controls, indicating that there is no important sharing of common risk alleles between the two neuropsychiatric disorders. Possibly, common risk alleles are less important in ASD in comparison to their more prominent role in schizophrenia and bipolar disorders. These findings provide important novel insights into shared and distinct elements of the genetic architecture of autism and schizophrenia. © 2012 Wiley Periodicals, Inc.

Auteur·ices de l’étude dans cette référence citée